News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Salient Surgical Technologies Expands TRANSCOLLATION(R) Technology into Brain Tumor Resection Procedures to Provide Quick and Effective Hemostasis


9/20/2010 8:20:53 AM

PORTSMOUTH, N.H.--(BUSINESS WIRE)--As part of its continuing efforts to improve patient outcomes by reducing surgical blood loss, Salient Surgical Technologies, Inc. today announced the availability of its AQUAMANTYS® bipolar sealer product line to US surgeons for use in brain tumor resection procedures.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES